StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Palisade Bio's price to sales ratio was 406.2× on Nov 11, 2026, against 41.3× a year earlier. Over the last 3 years it ranged from 14.8× to 468.7×, with a median of 90.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026406.2×+391.3
2024Apr 30, 202414.9×−6.8
2023Dec 29, 202321.7×−24.5
2019Jul 31, 201946.2×−9.8
2018Dec 31, 201856.0×−410.7
2012Oct 31, 2012466.7×–

More Palisade Bio figures

See a number that looks wrong?